{
    "SPADE_UN_22402": {
        "Sequence Information": {
            "Peptide Name": "LP-19",
            "Sequence": "EMTWEEWEKKVEELEKKIEELLX",
            "Sequence Length": 23,
            "Biological Activity": [
                "Antiviral"
            ],
            "Binding Target": "1. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Molecular Mechanism of HIV-1 Resistance to Sifuvirtide, a Clinical Trial-Approved Membrane Fusion Inhibitor.",
                    "Pubmed ID": "29929981",
                    "Reference": "J Biol Chem. 2018;293:12703-12718",
                    "Author": "Yu D, Ding X, Liu Z, Wu X, Zhu Y, Wei H, Chong H, Cui S, He Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29929981"
                }
            ],
            "SPADE ID": "SPADE_UN_22402",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22401",
                    "Similarity": 1.0,
                    "Sequence": "EMTWEEWEKKVEELEKKIEELLK"
                },
                {
                    "SPADE_ID": "SPADE_UN_22402",
                    "Similarity": 1.0,
                    "Sequence": "EMTWEEWEKKVEELEKKIEELL"
                },
                {
                    "SPADE_ID": "SPADE_UN_10728",
                    "Similarity": 0.8571428571428571,
                    "Sequence": "IEKKIEE"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1 NL4-3(IC50 I=0.00009µM),HIV-1 NL4-3 PsV(IC50 I=0.00007-0.00034µM)"
        }
    }
}